Addiction Medicine
News from the FDA/CDC
FDA moves to stop the spread of illicit ‘tranq’ in the U.S.
The agency “remains concerned about the increasing prevalence of xylazine mixed with illicit drugs,” said FDA Commissioner Robert M. Califf, MD....
Latest News
DEA proposals on telehealth for controlled substances draw fire
Both proposals would allow providers to prescribe a 30-day supply of a controlled substance or buprenorphine, but then require a face-to-face...
From the Journals
Buprenorphine proves effective for fentanyl users in the ED
A new study provides additional information about emergency department buprenorphine as fentanyl becomes increasingly prevalent.
Commentary
Joint effort: CBD not just innocent bystander in weed
‘I visited a legal cannabis dispensary in Massachusetts a few years ago, mostly to see what the hype was about.’
From the Journals
Repetitive TMS effective for comorbid depression, substance use
“I suspect this is just the beginning of a new era in neuromodulation-based therapeutics for people struggling with drug and alcohol use disorders...
Commentary
The X-waiver is dead
When Erin Schanning lost her brother to an overdose, she wanted to know what could have been done to have helped him.
From the Journals
Unexpected link between light drinking and dementia risk
A study offers new information on how risk changes over time as people change their drinking habits.
From the Journals
No spike in overdose deaths from relaxed buprenorphine regulations
“When my patients leave the hospital with a buprenorphine prescription, they are much less likely to return with another overdose or serious...
News from the FDA/CDC
Massive rise in drug overdose deaths driven by opioids
The total number of deaths caused by drug overdose exceeded 100,000 for the first time ever in 2021.
Latest News
Pandemic pregnancy-linked deaths up 35% from 2019
Drug-related deaths increased 55.3% and deaths from homicide increased 41.2%.
From the Journals
Psychiatric illnesses share common brain network
The findings highlight the possibility of “potentially developing transdiagnostic treatments based on common neurobiology, not just symptom...